The British medicines regulator on Monday authorised Eli Lilly’s NYSE:LLY pill Foundayo for weight management and type 2 diabetes, becoming Europe’s first country to do so.Lilly’s GLP-1 tablet, a once-daily drug that targets the GLP-1 hormone, has been gaining momentum in the U.S. since its approva…Read More
Lilly’s weight-loss pill gets UK regulator’s nod
By TradingView
